HEADER OXIDOREDUCTASE 15-MAY-11 3S1D TITLE GLU381SER MUTANT OF MAIZE CYTOKININ OXIDASE/DEHYDROGENASE COMPLEXED TITLE 2 WITH N6-ISOPENTENYLADENOSINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOKININ DEHYDROGENASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYTOKININ OXIDASE 1, CKO 1, COX 1, ZMCKX1; COMPND 5 EC: 1.5.99.12; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ZEA MAYS; SOURCE 3 ORGANISM_COMMON: MAIZE; SOURCE 4 ORGANISM_TAXID: 4577; SOURCE 5 STRAIN: CULTIVAR NOBILIS; SOURCE 6 GENE: CKX1; SOURCE 7 EXPRESSION_SYSTEM: YARROWIA LIPOLYTICA; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4952; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: PO1G; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PINA6703 KEYWDS OXIDOREDUCTASE, FAD BINDING PROTEIN, FLAVOPROTEIN, CYTOKININ KEYWDS 2 OXIDASE/DEHYDROGENASE, CYTOKININ BINDING, GLYCOSYLATION, COVALENT KEYWDS 3 FLAVINATION EXPDTA X-RAY DIFFRACTION AUTHOR D.KOPECNY,P.BRIOZZO,S.MORERA REVDAT 7 06-NOV-24 3S1D 1 REMARK REVDAT 6 13-SEP-23 3S1D 1 HETSYN REVDAT 5 29-JUL-20 3S1D 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 20-APR-16 3S1D 1 JRNL REVDAT 3 23-DEC-15 3S1D 1 JRNL REVDAT 2 04-NOV-15 3S1D 1 JRNL REVDAT 1 23-MAY-12 3S1D 0 JRNL AUTH D.KOPECNY,R.KONCITIKOVA,H.POPELKA,P.BRIOZZO,A.VIGOUROUX, JRNL AUTH 2 M.KOPECNA,D.ZALABAK,M.SEBELA,J.SKOPALOVA,I.FREBORT,S.MORERA JRNL TITL KINETIC AND STRUCTURAL INVESTIGATION OF THE CYTOKININ JRNL TITL 2 OXIDASE/DEHYDROGENASE ACTIVE SITE. JRNL REF FEBS J. V. 283 361 2016 JRNL REFN ISSN 1742-464X JRNL PMID 26519657 JRNL DOI 10.1111/FEBS.13581 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.8.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.62 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 64810 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 3288 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.79 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4778 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2739 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4543 REMARK 3 BIN R VALUE (WORKING SET) : 0.2731 REMARK 3 BIN FREE R VALUE : 0.2893 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.92 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 235 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3793 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 156 REMARK 3 SOLVENT ATOMS : 392 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.03 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : -0.02140 REMARK 3 B33 (A**2) : 0.05140 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.18290 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.272 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4044 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5519 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1314 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 106 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 626 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4044 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : 9 ; 0.000 ; HARMONIC REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 519 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4835 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.10 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.85 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3S1D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000065637. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NOT KNOWN REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64966 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.50500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.790 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3BW7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% (W/V) PEG 1500, 0.5% (W/V)N-OCTYL REMARK 280 BETA-D-GLUCOSIDE, 0.1 M TRIS-HCL, PH 7.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 125.51500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.20000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 125.51500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.20000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 19 REMARK 465 ALA A 20 REMARK 465 ALA A 21 REMARK 465 GLY A 22 REMARK 465 THR A 23 REMARK 465 PRO A 24 REMARK 465 ALA A 25 REMARK 465 LEU A 26 REMARK 465 GLY A 27 REMARK 465 ASP A 28 REMARK 465 ASP A 29 REMARK 465 ARG A 30 REMARK 465 GLY A 31 REMARK 465 ARG A 32 REMARK 465 GLY A 275 REMARK 465 GLY A 276 REMARK 465 GLY A 277 REMARK 465 GLY A 278 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 172 49.42 -91.13 REMARK 500 ASN A 181 -69.66 -106.21 REMARK 500 ALA A 182 -54.98 179.71 REMARK 500 PHE A 363 50.34 -101.42 REMARK 500 VAL A 414 -63.75 -108.68 REMARK 500 SER A 527 63.13 38.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3BW7 RELATED DB: PDB REMARK 900 THE SAME ENZYME COMPLEXED WITH THE MECHANISM-BASED INHIBITOR HA-1 REMARK 900 RELATED ID: 3C0P RELATED DB: PDB REMARK 900 THE SAME ENZYME COMPLEXED WITH THE MECHANISM-BASED INHIBITOR HA-8 REMARK 900 RELATED ID: 2QKN RELATED DB: PDB REMARK 900 THE SAME ENZYME COMPLEXED WITH THE PHENYLUREA INHIBITOR CPPU REMARK 900 RELATED ID: 1W1Q RELATED DB: PDB REMARK 900 THE SAME ENZYME COMPLEXED WITH ISOPENTENYLADENINE REMARK 900 RELATED ID: 1W1R RELATED DB: PDB REMARK 900 THE SAME ENZYME COMPLEXED WITH TRANS-ZEATIN REMARK 900 RELATED ID: 1W1S RELATED DB: PDB REMARK 900 THE SAME ENZYME COMPLEXED WITH BENZYLAMINOPURINE REMARK 900 RELATED ID: 3DQ0 RELATED DB: PDB REMARK 900 THE SAME ENZYME COMPLEXED WITH THE INHIBITOR N6-(3-METHOXY-PHENYL) REMARK 900 ADENINE REMARK 900 RELATED ID: 2QPM RELATED DB: PDB REMARK 900 LEU492ALA MUTANT OF THE SAME ENZYME COMPLEXED WITH THE BENZYLUREA REMARK 900 INHIBITOR CPBU REMARK 900 RELATED ID: 3KJM RELATED DB: PDB REMARK 900 LEU492ALA MUTANT OF THE SAME ENZYME COMPLEXED WITH THE PHENYLUREA REMARK 900 INHIBITOR CPPU REMARK 900 RELATED ID: 3S1C RELATED DB: PDB REMARK 900 RELATED ID: 3S1F RELATED DB: PDB REMARK 900 RELATED ID: 3S1E RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE CONFLICT IN UNP ENTRY Q9T0N8 AT THESE POSITIONS DBREF 3S1D A 19 534 UNP Q9T0N8 CKX1_MAIZE 19 534 SEQADV 3S1D ALA A 79 UNP Q9T0N8 GLY 79 SEE REMARK 999 SEQADV 3S1D THR A 168 UNP Q9T0N8 ASN 168 SEE REMARK 999 SEQADV 3S1D LEU A 254 UNP Q9T0N8 PHE 254 SEE REMARK 999 SEQADV 3S1D SER A 381 UNP Q9T0N8 GLU 381 ENGINEERED MUTATION SEQRES 1 A 516 LEU ALA ALA GLY THR PRO ALA LEU GLY ASP ASP ARG GLY SEQRES 2 A 516 ARG PRO TRP PRO ALA SER LEU ALA ALA LEU ALA LEU ASP SEQRES 3 A 516 GLY LYS LEU ARG THR ASP SER ASN ALA THR ALA ALA ALA SEQRES 4 A 516 SER THR ASP PHE GLY ASN ILE THR SER ALA LEU PRO ALA SEQRES 5 A 516 ALA VAL LEU TYR PRO SER SER THR ALA ASP LEU VAL ALA SEQRES 6 A 516 LEU LEU SER ALA ALA ASN SER THR PRO GLY TRP PRO TYR SEQRES 7 A 516 THR ILE ALA PHE ARG GLY ARG GLY HIS SER LEU MET GLY SEQRES 8 A 516 GLN ALA PHE ALA PRO GLY GLY VAL VAL VAL ASN MET ALA SEQRES 9 A 516 SER LEU GLY ASP ALA ALA ALA PRO PRO ARG ILE ASN VAL SEQRES 10 A 516 SER ALA ASP GLY ARG TYR VAL ASP ALA GLY GLY GLU GLN SEQRES 11 A 516 VAL TRP ILE ASP VAL LEU ARG ALA SER LEU ALA ARG GLY SEQRES 12 A 516 VAL ALA PRO ARG SER TRP THR ASP TYR LEU TYR LEU THR SEQRES 13 A 516 VAL GLY GLY THR LEU SER ASN ALA GLY ILE SER GLY GLN SEQRES 14 A 516 ALA PHE ARG HIS GLY PRO GLN ILE SER ASN VAL LEU GLU SEQRES 15 A 516 MET ASP VAL ILE THR GLY HIS GLY GLU MET VAL THR CYS SEQRES 16 A 516 SER LYS GLN LEU ASN ALA ASP LEU PHE ASP ALA VAL LEU SEQRES 17 A 516 GLY GLY LEU GLY GLN PHE GLY VAL ILE THR ARG ALA ARG SEQRES 18 A 516 ILE ALA VAL GLU PRO ALA PRO ALA ARG ALA ARG TRP VAL SEQRES 19 A 516 ARG LEU VAL TYR THR ASP PHE ALA ALA PHE SER ALA ASP SEQRES 20 A 516 GLN GLU ARG LEU THR ALA PRO ARG PRO GLY GLY GLY GLY SEQRES 21 A 516 ALA SER PHE GLY PRO MET SER TYR VAL GLU GLY SER VAL SEQRES 22 A 516 PHE VAL ASN GLN SER LEU ALA THR ASP LEU ALA ASN THR SEQRES 23 A 516 GLY PHE PHE THR ASP ALA ASP VAL ALA ARG ILE VAL ALA SEQRES 24 A 516 LEU ALA GLY GLU ARG ASN ALA THR THR VAL TYR SER ILE SEQRES 25 A 516 GLU ALA THR LEU ASN TYR ASP ASN ALA THR ALA ALA ALA SEQRES 26 A 516 ALA ALA VAL ASP GLN GLU LEU ALA SER VAL LEU GLY THR SEQRES 27 A 516 LEU SER TYR VAL GLU GLY PHE ALA PHE GLN ARG ASP VAL SEQRES 28 A 516 ALA TYR ALA ALA PHE LEU ASP ARG VAL HIS GLY SER GLU SEQRES 29 A 516 VAL ALA LEU ASN LYS LEU GLY LEU TRP ARG VAL PRO HIS SEQRES 30 A 516 PRO TRP LEU ASN MET PHE VAL PRO ARG SER ARG ILE ALA SEQRES 31 A 516 ASP PHE ASP ARG GLY VAL PHE LYS GLY ILE LEU GLN GLY SEQRES 32 A 516 THR ASP ILE VAL GLY PRO LEU ILE VAL TYR PRO LEU ASN SEQRES 33 A 516 LYS SER MET TRP ASP ASP GLY MET SER ALA ALA THR PRO SEQRES 34 A 516 SER GLU ASP VAL PHE TYR ALA VAL SER LEU LEU PHE SER SEQRES 35 A 516 SER VAL ALA PRO ASN ASP LEU ALA ARG LEU GLN GLU GLN SEQRES 36 A 516 ASN ARG ARG ILE LEU ARG PHE CYS ASP LEU ALA GLY ILE SEQRES 37 A 516 GLN TYR LYS THR TYR LEU ALA ARG HIS THR ASP ARG SER SEQRES 38 A 516 ASP TRP VAL ARG HIS PHE GLY ALA ALA LYS TRP ASN ARG SEQRES 39 A 516 PHE VAL GLU MET LYS ASN LYS TYR ASP PRO LYS ARG LEU SEQRES 40 A 516 LEU SER PRO GLY GLN ASP ILE PHE ASN MODRES 3S1D ASN A 63 ASN GLYCOSYLATION SITE MODRES 3S1D ASN A 294 ASN GLYCOSYLATION SITE MODRES 3S1D ASN A 323 ASN GLYCOSYLATION SITE HET FAD A 535 53 HET ZIR A 536 24 HET GOL A 537 6 HET GOL A 538 6 HET PEG A 539 7 HET GOL A 540 6 HET GOL A 541 6 HET GOL A 542 6 HET NAG A 543 14 HET NAG A 544 14 HET NAG A 545 14 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM ZIR N-(3-METHYLBUT-2-EN-1-YL)ADENOSINE HETNAM GOL GLYCEROL HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 FAD C27 H33 N9 O15 P2 FORMUL 3 ZIR C15 H21 N5 O4 FORMUL 4 GOL 5(C3 H8 O3) FORMUL 6 PEG C4 H10 O3 FORMUL 10 NAG 3(C8 H15 N O6) FORMUL 13 HOH *392(H2 O) HELIX 1 1 PRO A 35 ASP A 44 1 10 HELIX 2 2 ASP A 50 ALA A 57 1 8 HELIX 3 3 SER A 77 THR A 91 1 15 HELIX 4 4 ALA A 122 ASP A 126 5 5 HELIX 5 5 VAL A 149 ALA A 159 1 11 HELIX 6 6 THR A 174 SER A 180 1 7 HELIX 7 7 GLN A 187 GLY A 192 1 6 HELIX 8 8 PRO A 193 SER A 196 5 4 HELIX 9 9 ASN A 218 LEU A 226 1 9 HELIX 10 10 ASP A 258 ALA A 271 1 14 HELIX 11 11 SER A 296 ASN A 303 1 8 HELIX 12 12 THR A 308 ASN A 323 1 16 HELIX 13 13 ALA A 341 THR A 356 1 16 HELIX 14 14 TYR A 371 ASP A 376 1 6 HELIX 15 15 VAL A 378 LEU A 388 1 11 HELIX 16 16 ARG A 406 VAL A 414 1 9 HELIX 17 17 SER A 436 TRP A 438 5 3 HELIX 18 18 ALA A 463 ALA A 484 1 22 HELIX 19 19 ASP A 497 GLY A 506 1 10 HELIX 20 20 GLY A 506 ASP A 521 1 16 HELIX 21 21 SER A 527 ASP A 531 5 5 SHEET 1 A 4 LEU A 47 ARG A 48 0 SHEET 2 A 4 ALA A 71 LEU A 73 -1 O VAL A 72 N ARG A 48 SHEET 3 A 4 VAL A 117 ASN A 120 1 O ASN A 120 N LEU A 73 SHEET 4 A 4 ILE A 98 ARG A 101 1 N ALA A 99 O VAL A 119 SHEET 1 B 4 ILE A 133 VAL A 135 0 SHEET 2 B 4 TYR A 141 GLY A 145 -1 O ASP A 143 N ASN A 134 SHEET 3 B 4 GLY A 233 PRO A 244 -1 O ILE A 240 N VAL A 142 SHEET 4 B 4 VAL A 162 PRO A 164 -1 N ALA A 163 O GLU A 243 SHEET 1 C 5 ILE A 133 VAL A 135 0 SHEET 2 C 5 TYR A 141 GLY A 145 -1 O ASP A 143 N ASN A 134 SHEET 3 C 5 GLY A 233 PRO A 244 -1 O ILE A 240 N VAL A 142 SHEET 4 C 5 VAL A 198 THR A 205 -1 N GLU A 200 O ARG A 239 SHEET 5 C 5 MET A 210 CYS A 213 -1 O CYS A 213 N MET A 201 SHEET 1 D 4 TYR A 286 VAL A 293 0 SHEET 2 D 4 THR A 326 TYR A 336 -1 O GLU A 331 N GLU A 288 SHEET 3 D 4 ARG A 248 TYR A 256 -1 N VAL A 252 O ALA A 332 SHEET 4 D 4 ALA A 364 ALA A 370 -1 O VAL A 369 N ALA A 249 SHEET 1 E 4 LEU A 428 ASN A 434 0 SHEET 2 E 4 VAL A 451 LEU A 457 -1 O SER A 456 N ILE A 429 SHEET 3 E 4 LEU A 398 PRO A 403 -1 N LEU A 398 O LEU A 457 SHEET 4 E 4 LYS A 489 THR A 490 -1 O LYS A 489 N PHE A 401 LINK ND2 ASN A 63 C1 NAG A 543 1555 1555 1.45 LINK ND1 HIS A 105 C8M FAD A 535 1555 1555 1.56 LINK ND2 ASN A 294 C1 NAG A 544 1555 1555 1.52 LINK ND2 ASN A 323 C1 NAG A 545 1555 1555 1.54 CISPEP 1 ALA A 129 PRO A 130 0 -0.28 CRYST1 251.030 50.400 51.400 90.00 93.87 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.003984 0.000000 0.000269 0.00000 SCALE2 0.000000 0.019841 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019500 0.00000